disclosure received from Mr. sudhir sethi tthe main promoter of the company under regulation 29(2) of SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATION, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Ltd, acquired 11,786 equity shares (0.23% stake) through open market transactions on 10 March 2026. Before this purchase, he held 4,38,504 shares (8.65%), which has now increased to 4,50,290 shares (8.88%). The disclosure was filed under Regulation 29(2) of SEBI Takeover Regulations, 2011. Other promoters listed include Sanjay Sethi, Sangita Sethi, and Soniya Sethi. The total share capital of the company remains 50,71,700 equity shares.
This is a small open-market purchase by the main promoter, showing modest confidence in the company. The increase in promoter holding from 8.65% to 8.88% is a minor positive signal for retail investors, but the size of the transaction is too small to materially affect the share price.